PeptiDream Inc (PPTDF)
12.86
0.00 (0.00%)
USD |
OTCM |
May 10, 16:00
PeptiDream Revenue (Quarterly): 41.78M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 41.78M |
| September 30, 2023 | 90.82M |
| June 30, 2023 | 32.52M |
| March 31, 2023 | 37.58M |
| December 31, 2022 | 110.96M |
| September 30, 2022 | 44.77M |
| June 30, 2022 | 35.54M |
| March 31, 2022 | 3.611M |
| December 31, 2021 | 14.10M |
| September 30, 2021 | 44.54M |
| June 30, 2021 | 42.07M |
| March 31, 2021 | 13.95M |
| December 31, 2020 | 75.11M |
| September 30, 2020 | 6.832M |
| June 30, 2020 | 25.22M |
| March 31, 2020 | 3.616M |
| September 30, 2019 | 3.682M |
| June 30, 2019 | 39.04M |
| March 31, 2019 | 8.236M |
| December 31, 2018 | 12.98M |
| September 30, 2018 | 4.985M |
| Date | Value |
|---|---|
| June 30, 2018 | 48.50M |
| March 31, 2018 | 2.066M |
| December 31, 2017 | 6.569M |
| September 30, 2017 | 1.545M |
| June 30, 2017 | 31.31M |
| March 31, 2017 | 2.229M |
| December 31, 2016 | 3.369M |
| September 30, 2016 | 7.779M |
| June 30, 2016 | 15.24M |
| March 31, 2016 | 14.29M |
| December 31, 2015 | 5.314M |
| September 30, 2015 | 3.186M |
| June 30, 2015 | 15.98M |
| March 31, 2015 | 1.241M |
| December 31, 2014 | 2.155M |
| September 30, 2014 | 1.360M |
| June 30, 2014 | 2.170M |
| March 31, 2014 | 1.258M |
| December 31, 2013 | 2.922M |
| September 30, 2013 | 1.765M |
| June 30, 2013 | 1.962M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
3.611M
Minimum
Mar 2022
110.96M
Maximum
Dec 2022
36.98M
Average
36.56M
Median
Revenue (Quarterly) Benchmarks
| Takeda Pharmaceutical Co Ltd | 7.081B |
| Nxera Pharma Co Ltd | 31.07M |
| Healios KK | 0.0474M |
| AnGes Inc | 0.3408M |
| SanBio Co Ltd | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.424M |
| Total Expenses (Quarterly) | 41.64M |
| EPS Diluted (Quarterly) | -0.0263 |
| Enterprise Value | 1.685B |
| Gross Profit Margin (Quarterly) | 48.45% |
| Profit Margin (Quarterly) | -8.20% |
| Earnings Yield | 1.24% |
| Operating Earnings Yield | 2.78% |
| Normalized Earnings Yield | 1.244 |